Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma


Kahramanoglu I., DEMİRKIRAN F., TURAN H., BEŞE T. T., Cebi S., İLVAN Ş., ...More

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, vol.43, no.1, pp.34-42, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.1016/j.jogc.2020.06.021
  • Journal Name: JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.34-42
  • Keywords: carcinosarcoma, mixed tumor, mullerian, uterine neoplasms, radiotherapy, STAGE-I, RADIATION-THERAPY, SURVIVAL, PATTERNS, LYMPHADENECTOMY, GUIDELINES, SARCOMA, UTERUS, IMPACT
  • Istanbul University Affiliated: Yes

Abstract

Objective: To determine the impact of adjuvant therapy and other factors associated with the recurrence and survival of patients with uterine carcinosarcoma (UCS).